Branislav Jeremic

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi request reprint Clinical prognostic factors in patients with malignant glioma treated with combined modality approach
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:195-204. 2004
  2. ncbi request reprint Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:616-25. 2004
  3. ncbi request reprint Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Belgrade, Yugoslavia
    Int J Radiat Oncol Biol Phys 57:465-71. 2003
  4. ncbi request reprint Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    J Cancer Res Clin Oncol 129:477-84. 2003
  5. ncbi request reprint Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone
    Branislav Jeremic
    University Hospital, Kragujevac, Yugoslavia
    Lung Cancer 40:317-23. 2003
  6. ncbi request reprint Radiation therapy in small cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:297-307. 2004
  7. ncbi request reprint Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:350-60. 2004
  8. ncbi request reprint Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia, Yugoslavia
    Int J Radiat Oncol Biol Phys 59:509-14. 2004
  9. ncbi request reprint Radiation therapy
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:1-12. 2004
  10. ncbi request reprint Concurrent radiochemotherapy in the treatment of locally advanced non-small cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:91-100. 2004

Detail Information

Publications78

  1. ncbi request reprint Clinical prognostic factors in patients with malignant glioma treated with combined modality approach
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:195-204. 2004
    ..This study showed that sex, age, KPS, tumor size, tumor location, histology, and extent of surgery are independent prognosticators in patients with malignant glioma treated with combined modality approach...
  2. ncbi request reprint Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:616-25. 2004
    ..A carefully designed randomized trial seems necessary to give better insight into the issue of optimal IFI in this disease...
  3. ncbi request reprint Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Belgrade, Yugoslavia
    Int J Radiat Oncol Biol Phys 57:465-71. 2003
    ..To provide a 10-year update of hyperfractionated radiation therapy (Hfx RT) in adults with incompletely resected supratentorial low-grade glioma...
  4. ncbi request reprint Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    J Cancer Res Clin Oncol 129:477-84. 2003
    ..Multivariate analysis showed that gender and tumour location did not independently influence survival. When PFS was used as the endpoint, only gender did not influence PFS, as confirmed by multivariate analysis...
  5. ncbi request reprint Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone
    Branislav Jeremic
    University Hospital, Kragujevac, Yugoslavia
    Lung Cancer 40:317-23. 2003
    ..037) and CSS (P=0.039) but not LRFS (P=0.11). Multivariate analyses using OS, CSS and LRFS showed that the reason for not undergoing surgery affected OS (P=0.0436), but neither CSS (P=0.083) nor LRFS (P=0.080)...
  6. ncbi request reprint Radiation therapy in small cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:297-307. 2004
  7. ncbi request reprint Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Am J Clin Oncol 27:350-60. 2004
    ..High dose Hfx RT and concurrent low-dose daily CE with or without weekend CE is an active treatment approach in stage III NSCLC that led to high overall survival, LRFS, and DMFS rates...
  8. ncbi request reprint Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia, Yugoslavia
    Int J Radiat Oncol Biol Phys 59:509-14. 2004
    ..To provide updated outcome data (10 years) of a Phase II study of combined surgery, postoperative radiotherapy, and adjuvant chemotherapy in patients with anaplastic oligodendroglioma and oligoastrocytoma...
  9. ncbi request reprint Radiation therapy
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:1-12. 2004
    ..The future may, therefore, be quite simple: technology meets biology...
  10. ncbi request reprint Concurrent radiochemotherapy in the treatment of locally advanced non-small cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:91-100. 2004
    ..Newer RT technologies, third-generation CHT drugs, and widely used radioprotectors represent the current framework for numerous clinical studies that ultimately will help optimize the treatment of this disease...
  11. ncbi request reprint Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy
    Branislav Jeremic
    Department of Radiotherapy, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, 81675, Munich, Germany
    J Cancer Res Clin Oncol 129:114-22. 2003
    ..We investigated the influence of potential pre-treatment clinical prognostic factors in stage IV non-small cell lung cancer (NSCLC)...
  12. ncbi request reprint Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    J Clin Oncol 23:6873-80. 2005
    ..Feasibility and activity of concurrent hyperfractionated radiotherapy (Hfx RT) and low-dose, daily carboplatin and paclitaxel were investigated in patients with early-stage (I/II) non-small-cell lung cancer in a phase II study...
  13. ncbi request reprint Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Int J Radiat Oncol Biol Phys 68:426-32. 2007
    ....
  14. ncbi request reprint Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck
    Branislav Jeremic
    Department of Oncology and Head and Neck Surgery, University Hospital, Kragujevac, Serbia
    J Clin Oncol 22:3540-8. 2004
    ....
  15. doi request reprint Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Cancer 117:2995-3003. 2011
    ....
  16. ncbi request reprint No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Yugoslavia
    Lung Cancer 35:287-92. 2002
    ..These results give new insight about the influence of total dose/dose per fraction/interfraction interval with or without concurrent CHT on the thoracic spinal cord toxicity...
  17. ncbi request reprint Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Int J Radiat Oncol Biol Phys 65:1112-9. 2006
    ..To investigate influence of various pretreatment prognostic factors in patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone...
  18. ncbi request reprint Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    J Clin Oncol 23:1144-51. 2005
    ....
  19. doi request reprint Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Am J Clin Oncol 32:163-8. 2009
    ..Identification of pretreatment prognostic factors influencing overall survival (OS) in locally advanced squamous cell carcinoma of the head and neck is an important issue in head and neck oncology...
  20. doi request reprint Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Am J Clin Oncol 32:483-7. 2009
    ..To investigate impact of various pretreatment prognostic factors influencing distant metastasis-free survival (DMFS), in patients with locally advanced (stage III/IV), nonmetastatic squamous cell carcinoma of the head and neck...
  21. doi request reprint Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Int J Radiat Oncol Biol Phys 82:1157-63. 2012
    ..Our institutional experience with the use of hyperfractionated radiation therapy (RT) alone or concurrently with chemotherapy (RT-CHT) in Stage III non-small-cell lung cancer was reviewed...
  22. ncbi request reprint Radiation therapy alone in early stage non-small cell lung cancer
    Frank B Zimmermann
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Semin Surg Oncol 21:91-7. 2003
    ..RT is an effective treatment modality in technically operable, but medically inoperable patients with early stage NSCLC and offers a long-lasting cure...
  23. doi request reprint Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Radiother Oncol 87:201-3. 2008
    ..In locally controlled tumors cisplatin led to better DMFS (p=0.0272); Cisplatin may have acted independently of micrometastasis in locally advanced H&N cancer...
  24. ncbi request reprint Curative approaches to lung cancer in the elderly
    Martin Weinmann
    Department of Radiation Oncology, University Hospital, Tubingen, Germany
    Semin Surg Oncol 21:182-9. 2003
    ..When adequate patient selection is provided, standard treatment approaches appear to be feasible for elderly (>70 years) patients with good performance status...
  25. ncbi request reprint Limited-disease small-cell lung cancer
    Frank B Zimmermann
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Semin Surg Oncol 21:156-63. 2003
    ..The value of surgery is limited to peripheral tumors and poorly responding cancer, and to confirm histology or improve local control and survival...
  26. doi request reprint Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Clin Transl Oncol 14:613-8. 2012
    ..to investigate toxicity of hyperfractionated radiation therapy (Hfx RT) with or without concurrent chemotherapy (CHT) in patients with locally advanced non-small cell lung cancer (NSCLC) and factors independently influencing it...
  27. doi request reprint Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Am J Clin Oncol 31:213-8. 2008
    ..To investigate various pretreatment prognostic factors influencing local recurrence-free survival (LRFS) in locally advanced squamous cell carcinoma of the head and neck...
  28. ncbi request reprint Radiation therapy and chemotherapy in the treatment of limited-disease small cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:343-53. 2004
  29. ncbi request reprint L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy
    Anca Ligia Grosu
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Int J Radiat Oncol Biol Phys 63:64-74. 2005
    ..The goal of this trial was to quantify the affect of MET-PET vs. with MRI in gross tumor volume definition for radiotherapy planning of high-grade gliomas...
  30. ncbi request reprint Positron emission tomography for radiation treatment planning
    Anca Ligia Grosu
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University, Munich, Germany
    Strahlenther Onkol 181:483-99. 2005
    ..To evaluate the impact of positron emission tomography (PET) on target volume delineation for radiation treatment planning...
  31. ncbi request reprint Treatment of small cell lung cancer in the elderly
    Branislav Jeremic
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:433-43. 2004
  32. doi request reprint From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Cancer 112:876-84. 2008
    ....
  33. ncbi request reprint Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer
    Frank B Zimmermann
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University, Ismaninger Strasse 22, D 81675 Munich, Germany
    Lung Cancer 48:107-14. 2005
    ..SFRT is a feasible and safe treatment method in inoperable patients with stage I NSCLC having reduced lung capacity. Longer follow-up is necessary to get robust data on late toxicity as well as survival...
  34. ncbi request reprint Treatment of recurrent disease in lung cancer
    Frank B Zimmermann
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Semin Surg Oncol 21:122-7. 2003
    ....
  35. ncbi request reprint Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma
    Gerd Becker
    Department of Radiation Oncology, University Hospital, Tubingen, Germany
    Int J Radiat Oncol Biol Phys 54:1422-9. 2002
    ..METHODS AND MARERIALS: Between 1994 and 2000, a total of 39 patients with either primary (n = 15) or secondary (n = 24) ONSM were treated with SFRT and received a median total tumor dose of 54 Gy using 1.8 Gy/fraction...
  36. ncbi request reprint Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas
    Frank B Zimmermann
    Klinik fuer Strahlentherapie und Radiologische Onkologie, Klinikum rechts der Isar, Technische Universitaet Muenchen, Germany
    Hepatogastroenterology 52:246-50. 2005
    ..To investigate the advantages and palliative effectiveness of concurrent hypofractionated radiotherapy (RT) and chemotherapy (5-FU) in patients with locally advanced and metastatic adenocarcinoma of the pancreas...
  37. ncbi request reprint Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer
    Martin Weinmann
    Department of Radiation Oncology, University of Tubingen, Hoppe Seyler Strasse 3, 72076, Tubingen, Germany
    Lung Cancer 39:233-53. 2003
    ..Currently, single-agent CHT should be considered as the standard treatment of advanced NSCLC elderly patients...
  38. ncbi request reprint Treatment of lung cancer in elderly part II: small cell lung cancer
    Martin Weinmann
    Department of Radiation Oncology, University of Tubingen, Hoppe Seyler Strasse 3, 72076, Tubingen, Germany
    Lung Cancer 40:1-16. 2003
    ..For the comparison of trials in elderly patients it will be of key importance to include a comprehensive and standardised geriatric assessment in such studies...
  39. ncbi request reprint External beam radiation therapy for bronchial stump recurrence of non-small-cell lung cancer after complete resection
    Branislav Jeremic
    Department of Radiation Oncology, University Hospital, Hoppe Seyler Strasse 3, D 72076 Tuebingen, Germany
    Radiother Oncol 64:251-7. 2002
    ..The objective of this review is to determine effectiveness of high-dose EBRT in this disease...
  40. ncbi request reprint Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer
    Branislav Jeremic
    Department of Radiation Oncology, University Hospital, Tubingen, Germany
    Int J Radiat Oncol Biol Phys 54:119-130. 2002
    ..To investigate the effectiveness of high-dose, curative radiotherapy (RT) given alone in technically operable, but medically inoperable, patients with early-stage (I-II) non-small-cell lung cancer (NSCLC)...
  41. doi request reprint Radiotherapy alone vs. radiochemotherapy in patients with favorable prognosis of clinical stage IIIA non-small-cell lung cancer
    Branislav Jeremic
    Department of Oncology, University Hospital, Kragujevac, Serbia
    Clin Lung Cancer 14:172-80. 2013
    ..radiochemotherapy (RT-CHT) in patients with locally advanced, inoperable non-small-cell lung cancer who had a "favorable" prognosis (stage IIIA, Karnofsky performance score 70-100, no weight loss >5%)...
  42. ncbi request reprint Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer
    Carsten Nieder
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str 22, 81675 Munich, Germany
    Anticancer Res 23:5117-23. 2003
    ..In virtually all large studies with multivariate analysis, their influence was higher than that of emerging factors...
  43. ncbi request reprint Treatment of locally advanced and metastatic non-small cell lung cancer in the elderly
    Frank B Zimmermann
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D 81675 Munich, Germany
    Hematol Oncol Clin North Am 18:203-13. 2004
    ..Many questions concerning the optimal treatment for elderly patients with NSCLC remain unanswered and more trials designed for the elderly are urgently needed in the future...
  44. ncbi request reprint Radiotherapy-induced lung toxicity: risk factors and prevention strategies
    Carsten Nieder
    Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str 22, 81675 Munich, Germany
    Anticancer Res 23:4991-8. 2003
    ..This review summarizes translational research data as well as clinical strategies for response modification and prediction...
  45. ncbi request reprint Radiosurgery for brain metastases: the Tuebingen experience
    Gerd Becker
    Department of Radiotherapy, University Hospital, Tuebingen, Germany
    Radiother Oncol 62:233-7. 2002
    ..To retrospectively investigate the effectiveness of linear accelerator based radiosurgery (RS) in the treatment of brain metastases (BM)...
  46. ncbi request reprint Elective neck irradiation in locally advanced squamous cell carcinoma of the maxillary sinus: a review
    Branislav Jeremic
    University Hospital, Department of Radiation Oncology, University of Tuebingen, Hoppe Seyler Strasse 3, 72076 Tuebingen, Germany
    J Cancer Res Clin Oncol 128:235-8. 2002
    ..However, given the background of only a few studies addressing this issue and anticipated better local control with the newer technologies, this issue needs to be properly studied in the future...
  47. pmc Continuous controllable balloon dilation: a novel approach for cervix dilation
    Slobodan Arsenijevic
    Center for Molecular Medicine and Stem Cell Research Faculty of Medicine, University of Kragujevac, 69 Svetozara Markovica Street, Kragujevac, 34 000, Serbia
    Trials 13:196. 2012
    ..To achieve safe and painless cervical dilation, we constructed a new medical device to achieve confident mechanical cervical dilation: a continuous controllable balloon dilator (CCBD)...
  48. ncbi request reprint Second single 4 Gy reirradiation for painful bone metastasis
    Branislav Jeremic
    University Hospital, Kragujevac, Yugoslavia
    J Pain Symptom Manage 23:26-30. 2002
    ..In this small and highly selected series of patients, the third single fraction RT of 4 Gy was effective and not toxic in the treatment of painful bone metastasis...
  49. ncbi request reprint Second primary cancers occurring in patients with early stage non-small-cell lung cancer treated with radiation therapy alone
    Branislav Jeremic
    Eur J Cardiothorac Surg 22:1039-40; author reply 1040-1. 2002
  50. ncbi request reprint Patterns of practice of palliative radiotherapy in Africa, Part 1: Bone and brain metastases
    Vinay Sharma
    Department of Radiation Oncology, Johannesburg Hospital, University of Witwatersrand, Johannesburg, South Africa
    Int J Radiat Oncol Biol Phys 70:1195-201. 2008
    ..To provide data on the pattern of practice of palliative radiotherapy (RT) on the African continent...
  51. ncbi request reprint Low incidence of isolated nodal failures after involved-field radiation therapy for non small-cell lung cancer: blinded by the light?
    Branislav Jeremic
    J Clin Oncol 25:5543-5. 2007
  52. ncbi request reprint Lung cancer management in limited resource settings: guidelines for appropriate good care
    Fergus R Macbeth
    National Collaborating Centre for Cancer, Cardiff, UK
    Radiother Oncol 82:123-31. 2007
    ..These tables can be used to assess the cost-effectiveness and appropriateness of different interventions in a particular health care system and to develop local clinical guidelines...
  53. doi request reprint Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again
    Branislav Jeremic
    J Clin Oncol 26:e1-2. 2008
  54. ncbi request reprint Survival after resection of metachronous non-small cell lung cancer
    Branislav Jeremic
    Ann Thorac Surg 73:1694. 2002
  55. ncbi request reprint In regard to Sim et al., IJROBP 2001;51:660-665
    Branislav Jeremic
    Int J Radiat Oncol Biol Phys 53:512-3; author reply 513. 2002
  56. doi request reprint Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC)
    Gregory M M Videtic
    Department of Radiation Oncology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 72:327-34. 2008
    ....
  57. doi request reprint Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC)
    Jose S A Belderbos
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 72:335-42. 2008
    ..The purpose of this report is to analyze the current status of ENI and to provide comprehensive in-depth analysis and guidance on how to generally approach this issue in NSCLC...
  58. ncbi request reprint Radiation therapy in the multimodal treatment approach of pituitary adenoma
    Gerd Becker
    Radiooncologic University Clinic, Tubingen, Germany
    Strahlenther Onkol 178:173-86. 2002
    ..In this paper, literature will be reviewed to assess the role of modern radiotherapy and radiosurgery in the management of pituitary adenomas...
  59. ncbi request reprint Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey
    Lucyna Kepka
    Department of Radiotherapy, Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, ul Roentgena 5, 02 781 Warsaw, Poland
    Lung Cancer 56:235-45. 2007
    ..To assess resources and management strategies for the use of radiotherapy (RT) in the treatment of lung cancer in developing Central and Eastern European countries...
  60. ncbi request reprint Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
    Branislav Jeremic
    Radiother Oncol 71:123-5. 2004
  61. ncbi request reprint Radiation therapy alone as an alternative to surgery in patients with early stage non-small-cell lung cancer having cardiovascular (and other) comorbidity
    Branislav Jeremic
    Eur J Cardiothorac Surg 25:297. 2004
  62. ncbi request reprint Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?
    Rolf Dieter Kortmann
    Department of Radiooncology, University of Tuebingen, Germany
    Strahlenther Onkol 180:408-18. 2004
    ..It is still an open question in which clinical setting immediate radiotherapy should be considered and whether chemotherapy may become a useful alternative...
  63. ncbi request reprint Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity
    Rolf Dieter Kortmann
    Department of Radiooncology, University of Tubingen, Germany
    Strahlenther Onkol 179:585-97. 2003
    ..As this tumor carries an excellent long-term prognosis, the risk of late effects is of particular clinical importance and impinges upon radiotherapeutic treatment strategies...
  64. ncbi request reprint Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy
    Rolf Dieter Kortmann
    Department of Radiooncology, University of Tubingen, Germany
    Strahlenther Onkol 179:509-20. 2003
    ..Treatment of childhood low-grade gliomas is a challenging issue owing to their low incidence and the lack of consensus about "optimal" treatment approach...
  65. ncbi request reprint Necessity of identifying the patterns of failure after concurrent radiochemotherapy part of a combined modality approach in patients with stage III non-small cell lung cancer [Sakai et al., Lung Cancer 2004;43:195-201]
    Branislav Jeremic
    Lung Cancer 46:263-4. 2004
  66. ncbi request reprint Complex and controversial issues in locally advanced non-small cell lung carcinoma
    Mitchell Machtay
    University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA
    Semin Surg Oncol 21:128-37. 2003
    ..This article summarizes the advances in the treatment of locally advanced NSCLC over the past several decades and explores some of the many remaining controversies and areas for future investigation...
  67. ncbi request reprint In regard to Bogart et al.: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage non-small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 (Int J Radiat Oncol Biol Phys 2004;59:460-468)
    Francesc Casas
    Int J Radiat Oncol Biol Phys 60:1661-2; author reply 1662-3. 2004
  68. ncbi request reprint Predictors of radiation pneumonitis after radiotherapy in lung cancer
    Branislav Jeremic
    Int J Radiat Oncol Biol Phys 61:302. 2005
  69. ncbi request reprint Patterns of care survey (PCS) in chemotherapy (CHT) in nonmetastatic lung cancer
    Branislav Jeremic
    Lung Cancer 48:103-5. 2005
  70. ncbi request reprint Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer
    Branislav Jeremic
    J Thorac Cardiovasc Surg 125:444-5. 2003
  71. ncbi request reprint Radiation therapy alone in elderly with early stage non-small cell lung cancer
    Sol San José
    Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain
    Lung Cancer 52:149-54. 2006
    ..We retrospectively investigated the effectiveness of RT alone in this patient population treated in our institution...
  72. ncbi request reprint Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: "Meta-analysis of meta-analyses"
    Branislav Jeremic
    Int J Radiat Oncol Biol Phys 64:981-2. 2006
  73. ncbi request reprint [Combined radiochemotherapy in localised small-cell lung cancer. Concurrent treatment protocols?]
    Ana Lucas Calduch
    Servicio de Oncologia Radioterapica, Institut Catala d Oncologia, Barcelona, Espana
    Clin Transl Oncol 7:314-20. 2005
    ..We retrospectively reviewed our Institution's database to investigate the outcome and impact of combined radiochemotherapy (RT/CT; concomitant or in sequence) in localised small-cell lung cancer (L-SCLC)...
  74. ncbi request reprint Radiochemotherapy of malignant glioma in adults. Clinical experiences
    Rolf Dieter Kortmann
    Department for Radiation Oncology, University of Tubingen, Germany
    Strahlenther Onkol 179:219-32. 2003
    ..Standard treatment in patients with malignant glioma consists of surgery and postoperative radiotherapy. A high early recurrence rate, particularly in glioblastoma, has led to the investigation of additional chemotherapy...
  75. ncbi request reprint Induction chemotherapy followed by concurrent chemoradiotherapy and operation in locally advanced non-small cell lung cancer
    Branislav Jeremic
    Ann Thorac Surg 76:979. 2003
  76. ncbi request reprint Adjuvant neck dissection after concurrent chemoradiation for advanced head-and-neck cancer: in regard to Brizel et al. (Int J Radiat Oncol Biol Phys 2004;58: 1418-1423)
    Branislav Jeremic
    Int J Radiat Oncol Biol Phys 60:1338. 2004
  77. ncbi request reprint Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice
    Branislav Jeremic
    Applied Radiation Biology and Radiotherapy, International Atomic Energy Agency, Vienna, Austria
    Cancer 110:714-22. 2007
    ..Recently, stereotactic fractionated RT (SFRT) has been introduced as a tool with better precision for RT delivery. A comprehensive review was undertaken to provide more insight into this matter...
  78. ncbi request reprint Observation-only management of inoperable lung cancer: do not do that: a loud and clear radiographic point of view!
    Branislav Jeremic
    Chest 123:313-4; author reply 314-5. 2003